Skip to main content
lexblog.com/lib/29VB551Gviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "UK Public Procurement Landscape Transformed: What Does It Mean for Medicines?",
    "url": "https://www.lexblog.com/2025/03/27/uk-public-procurement-landscape-transformed-what-does-it-mean-for-medicines/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-29VB551G",
        "url": "https://www.lexblog.com/lib/29VB551G/"
    },
    "datePublished": "2025-03-27T08:08:08-04:00",
    "dateModified": "2026-02-25T11:39:43-05:00",
    "author": {
        "@type": "Person",
        "name": "Heba Jalil, Arnold & Porter"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Arnold & Porter Kaye Scholer LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "BioSlice Blog",
    "about": "Administrative and Regulatory ยท Government Contracts",
    "sourceUrl": "https://www.biosliceblog.com/?p=3703",
    "sourceStability": "may-move"
}